ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,792 | -32.7% | 811 | -10.7% | 0.00% | – |
| Q2 2023 | $32,379 | -98.6% | 908 | -98.4% | 0.00% | -100.0% |
| Q4 2022 | $2,297,805 | -89.6% | 56,652 | -91.5% | 0.01% | -90.9% |
| Q3 2022 | $22,031,000 | +58.1% | 666,600 | +68.4% | 0.09% | +49.2% |
| Q2 2022 | $13,939,000 | -46.0% | 395,868 | -29.4% | 0.06% | -42.2% |
| Q1 2022 | $25,805,000 | +778.6% | 561,100 | +1166.8% | 0.10% | +750.0% |
| Q4 2021 | $2,937,000 | -70.7% | 44,292 | -72.4% | 0.01% | -72.7% |
| Q3 2021 | $10,020,000 | +116.4% | 160,500 | +187.1% | 0.04% | +109.5% |
| Q2 2021 | $4,630,000 | -91.9% | 55,900 | -95.8% | 0.02% | -92.9% |
| Q3 2020 | $57,395,000 | +11.7% | 1,332,899 | +12.0% | 0.29% | -12.2% |
| Q2 2020 | $51,388,000 | +30671.3% | 1,189,807 | +12979.1% | 0.34% | +33400.0% |
| Q1 2019 | $167,000 | +169.4% | 9,097 | +7.0% | 0.00% | – |
| Q3 2016 | $62,000 | -95.4% | 8,500 | -96.7% | 0.00% | -100.0% |
| Q2 2016 | $1,362,000 | – | 256,101 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |